Inventor
OLSON WILLIAM C
US30 patents
⚠️ This page may combine multiple inventors who share the name “OLSON WILLIAM C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROGENICS PHARM INC
18 patentsUS6344545B1Feb 5, 2002
Method for preventing HIV-1 infection of CD4+ cells
PROGENICS PHARM INC91 citations97
US6107019AAug 22, 2000
Method for preventing HIV-1 infection of CD4+ cells
PROGENICS PHARM INC78 citations96
US6710173B1Mar 23, 2004
Stabilized viral envelope proteins and uses thereof
PROGENICS PHARM INC36 citations95
US7138119B2Nov 21, 2006
Compositions and methods for inhibition of HIV-1 infection
PROGENICS PHARM INC24 citations93
US7060273B2Jun 13, 2006
Methods for inhibiting HIV-1 infection
PROGENICS PHARM INC32 citations93
US6692745B2Feb 17, 2004
Compositions and methods for inhibition of HIV-1 infection
PROGENICS PHARM INC37 citations93
US6548636B2Apr 15, 2003
Sulfated CCR5 peptides for HIV-1 infection
PROGENICS PHARM INC54 citations93
US7939083B2May 10, 2011
Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain
PROGENICS PHARM INC55 citations92
US7666419B2Feb 23, 2010
Anti-CCR5 antibody
PROGENICS PHARM INC14 citations91
US7592014B2Sep 22, 2009
Stabilized viral envelope proteins and uses thereof
PROGENICS PHARM INC34 citations91
US7022324B2Apr 4, 2006
Stabilized viral envelope proteins and uses thereof
PROGENICS PHARM INC31 citations91
US7479553B2Jan 20, 2009
Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins
PROGENICS PHARM INC4 citations72
US7851600B2Dec 14, 2010
Anti-CCR5 antibody
PROGENICS PHARM INC3 citations63
US7022323B2Apr 4, 2006
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
PROGENICS PHARM INC3 citations63
US7935797B2May 3, 2011
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
PROGENICS PHARM INC1 citations52
US7858298B1Dec 28, 2010
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
PROGENICS PHARM INC1 citations52
US7736649B2Jun 15, 2010
Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors
PROGENICS PHARM INC1 citations52
US7446177B2Nov 4, 2008
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
PROGENICS PHARM INC0 citations52